- Expanding OnPoint CTMS and SharePoint Implementation Services for International Clinical Trials -
NEWTOWN, Pennsylvania, June 26, 2013 /PRNewswire/ -- BioClinica®, Inc., a global provider of clinical trial management solutions, today announced a partnership with NNIT, a leading Life Science IT solutions company to implement and integrate BioClinica OnPoint CTMS (Clinical Trial Management System) and Microsoft® SharePoint extensions for international clinical trial sponsors.
CTMS applications are used to manage business and operational processes for clinical trials. BioClinica OnPoint is a Microsoft Office-Smart CTMS integrated with SharePoint to enable superior team collaboration, connectivity and flexibility in multi-site environments. OnPoint capabilities include: clinical site management; personnel, patient and clinical supplies administration; scheduling, tracking and performance monitoring; site payments, study document management; and more.
"This collaboration with NNIT moves BioClinica closer to our goal of bringing the science of managing clinical trials into the 21st century," said Peter Benton, eClinical President for BioClinica. "The unprecedented pressures on clinical research require accurate, flexible and reliable tools to manage cost and risk. This necessitates better technology. The technical and domain experience of BioClinica and NNIT offers a combination of the best solutions in the industry for the benefit of our mutual clients."
With a dedicated Life Sciences System Integration organization of more than 550 people across Europe, China and the US, the partnership will significantly build up BioClinica's global implementation capabilities by leveraging NNIT's international presence, proven project management and system integration expertise for life sciences companies.
Torben Thorhauge, Vice President, Life Sciences Industry Practice, NNIT said: "NNIT is extremely pleased to partner with BioClinica on the OnPoint CTMS Solution. OnPoint is a fast, user-friendly, configurable user interface that has been used by major pharma clients for more than 10 years, and has a proven record of use within highly validated and controlled Life Sciences customers. This alliance provides us with the software tools necessary to address the challenges faced by Life Sciences companies looking to move to newer technology based on the Microsoft platform."
NNIT is one of Europe's leading consultancies in the development, implementation, validation and operation of IT for the life sciences industry. NNIT meets the industry's strictest requirements for quality. For over a decade, NNIT has applied the latest advances in technology to make clients' software, business processes and communication more effective. NNIT employs more than 2,000 people and in 2012, turnover was €268 million. For more information please visit www.nnit.com.
About BioClinica, Inc.
BioClinica, Inc. is a global provider of integrated, technology-enhanced clinical trial management services. The 2013 merger with CoreLab Partners created a new leader in imaging core lab services including electronic transfer, management, and independent review; cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis; and eClinical solutions for electronic data capture, randomization, clinical trial management, and clinical supply chain forecasting and optimization. BioClinica offers unmatched scientific expertise with a team of respected medical researchers and board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. With more than 28 years of experience and over 3000 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide comprehensive cardiovascular safety, and eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.
SOURCE BioClinica, Inc.